Exit comparison

Removed

Added

Datasets Comparison

Version 1

TNFi is associated with decreased risk of COVID-19 related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate.”

Published:12 January 2022|Version 1|DOI:10.17632/tvvwmbry4h.1

Contributor:Rachel Tallman

Description

Supplementary Appendix

Institutions

Institutions

West Virginia University

Categories

Dermatology

Licence

Creative Commons Attribution 4.0 International

Version 2

TNFi is associated with decreased risk of COVID-19 related hospitalization: Follow up of “Clinical outcomes of COVID-19 in patients taking tumor necrosis factor inhibitors and methotrexate.”

Published:27 June 2022|Version 2|DOI:10.17632/tvvwmbry4h.2

Contributor:Rachel Tallman

Description

Supplementary Appendix

Institutions

Institutions

West Virginia University

Categories

Dermatology

Licence

Creative Commons Attribution 4.0 International